Georges De Feu

Georges De Feu has worked in various roles in the healthcare industry since 2009. Starting as a stagiair at Servier in 2009, they then worked as a stagiair apotheker at Multipharma in 2011. In 2012, they co-founded Qualenica (now Magis Pharma) and served as Chairman of the Board. In 2013, they founded IusStart and worked as Zaakvoerder at PharmaLegal BVBA. Georges then co-founded Zorgpunt cvba in 2015, where they were responsible for the financial and business model and achieved double digit growth year-over-year. In 2019, they became an angel investor and Director of Asylia Diagnostics BV, a diagnostics technology platform intended to provide safer immunotherapy for cancer patients. Finally, they co-founded LynxCare, Inc. in 2015, where they served as CEO and set up the business model, built the initial base of hospital and pharma clients, set up a US entity, and raised over 25 million in finances with a team of 45 FTE.

Georges De Feu completed their Bachelor in de Rechten at KU Leuven in 2007, followed by a Bachelor of Pharmacy - BPharm in 2010. Georges then pursued a Master of Laws - LLM in Intellectual Property Rights at KU Leuven from 2013 to 2015. Prior to this, Georges De Feu had studied Corporate and Organisational Strategy at The London School of Economics and Political Science (LSE). Georges also completed a thesis at Max Planck - Center for Molecular Biomedicine (CMB) at Friedrich-Schiller-Universität Jena. Additionally, Georges De Feu studied Greek (Ancient) and Mathematics at Jan-van-Ruusbroeckollege Brussels - Jesuit college from 2001 to 2007.